3 Stocks Underperforming Today In The Health Services Industry
All three major indices are trading up today with the
Dow Jones Industrial Average
(
^DJI
) trading up 27 points (0.2%) at 17,957 as of Friday, July 1, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,893 issues advancing vs. 1,079 declining with 105 unchanged.
The Health Services industry currently sits up 0.9% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was
(
), up 0.5%.
TheStreet would like to highlight 3 stocks pushing the industry lower today:
3.
(
) is one of the companies pushing the Health Services industry lower today. As of noon trading, Edwards Lifesciences is down $0.95 (-0.9%) to $98.78 on light volume. Thus far, 614,428 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $98.28-$99.83 after having opened the day at $99.83 as compared to the previous trading day's close of $99.73.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $20.5 billion and is part of the health care sector. Shares are up 26.3% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts that rate Edwards Lifesciences a buy, no analysts rate it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Edwards Lifesciences
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full
Edwards Lifesciences Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is down $3.15 (-1.8%) to $176.73 on heavy volume. Thus far, 1.4 million shares of Humana exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $175.60-$181.21 after having opened the day at $181.21 as compared to the previous trading day's close of $179.88.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. Humana has a market cap of $27.4 billion and is part of the health care sector. Shares are up 0.8% year-to-date as of the close of trading on Thursday. Currently there are 6 analysts that rate Humana a buy, no analysts rate it a sell, and 9 rate it a hold.
TheStreet Ratings rates
Humana
as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is down $2.18 (-1.8%) to $119.95 on average volume. Thus far, 1.3 million shares of Aetna exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $119.95-$121.70 after having opened the day at $121.53 as compared to the previous trading day's close of $122.13.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $42.5 billion and is part of the health care sector. Shares are up 13.0% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts that rate Aetna a buy, 1 analyst rates it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Aetna
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).